An Advanced Personalised Therapeutics in Gynaecological Cancers Symposium is taking place at St Hugh’s College on 21 February 2020, to which you are all welcome to attend. Registration is free but only limited spaces are available. To register, please go to: https://forms.gle/T9ZKFF7Ttxctw1HYA This will be a full day meeting with a start of registration at 8.30 am and a close at 6 pm. For a description of the symposium and a list of confirmed speakers, please see this document. The full program of the symposium will be uploaded soon to the registration web page.
Organised by IHTM MSc students, Alice in Typhoidland will provide fun for the family and other curious visitors. Sat 25 Jan, 12-4pm at Blackwell Hall, Weston Library. Join Alice on a journey through the history of early typhoid control and discover how typhoid influenced the design of the water and sewage systems under our feet. Solve the riddle of mysterious typhoid outbreaks in Victorian Oxford, and find out how doctors and engineers controlled typhoid to stop the disease from spreading.
Professor Chas Bountra is interested in identifying and validating target proteins for drug discovery. Various technologies and strategies have allowed him to progress promising clinical candidates into Phase I, II, III studies, and to market. These new drugs offer novel treatments for neurodegenerative and gastrointestinal diseases, as well as pain disorders.
It is with profound sadness that we learnt of the death of our colleague Professor Vincenzo Cerundolo FRS. Professor Cerundolo was Director of the MRC Human Immunology Unit at the MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine. He had previously been a long time member of NDM. He leaves a loving wife and two children, of whom he was very proud. Enzo was particularly happy to have been able to enjoy seeing his daughter marry in 2019 and for his son to have a successful start to university life. He will be greatly missed.
Congratulations to NDM's Sergi Padilla-Parra, who has been successful in obtaining one of the nine new ERC Consolidator Grants, the most awarded to any institution in the UK and second place in Europe. ERC Consolidator Grants are awarded to outstanding researchers of any nationality and age, with at least seven and up to 12 years of experience after PhD, and a scientific track record showing great promise!
A specialist technique used to study drugs has been completed for the first time during an outbreak of Ebola virus disease. This study used pharmacokinetics – the measurement of the change in drug concentration in a person over time – to study an experimental drug for the treatment of Ebola virus disease during the 2015 outbreak in Sierra Leone.